Pharma Pulse 3/12/25: Trump Doubles Canadian Tariffs on Steel and Aluminum, Educating Patients to Improve Adherence & more

President Trump to Double Tariffs on Canadian Steel and Aluminum

The updated tax on Canadian imports will rise from 25% to 50%, taking effect March 12.

Educating Patients About Adverse Effects Can Improve Adherence

In this interview with Pharmacy Times, Matthew Zirwas, MD, discusses common misconceptions and adherence challenges surrounding topical ruxolitinib (Opzelura; Incyte Dermatology) in vitiligo and atopic dermatitis. He addresses patient fears stemming from the medication’s boxed warning, clarifying that the risks primarily pertain to systemic JAK inhibitors, not topical formulations. He further differentiates treatment approaches for vitiligo and atopic dermatitis, emphasizing the importance of consistent application for vitiligo on the face and a proactive, as-needed strategy for atopic dermatitis to maximize efficacy and patient quality of life.

The Quest for A.I. ‘Scientific Superintelligence’

An ambitious start-up embodies new optimism that artificial intelligence can turbocharge scientific discovery.

PerkinElmer Acquires Project Farma, Expanding Its OneSource Professional Services Offering for the Life Sciences Industry

PerkinElmer announced the acquisition of Project Farma, a subsidiary of Precision for Medicine. Project Farma is a leading life sciences consultancy focused on advancing technical operations from ideation through commercialization, offering project management, project controls, commissioning, qualification and validation, quality compliance and engineering consulting services. Terms of the acquisition were not disclosed.

Miranda Schmalfuhs on LinkedIn

Check out my extended conversation with Pleio CCO, Jennifer Butler on this week's episode of the Pharmaceutical Executive podcast!

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs